Schedule an Appointment
Already a Patient? Connect on My IU Health
- Biography
- Insurance
- Locations
- Specialties & Details
- Ratings & Reviews
- Clinical Trials
- Related Stories
Biography
Dr. Patrick J. Loehrer specializes in Cancer Treatment for Multi-D Oncology Clinic. Dr. Loehrer earned his medical degree at Rush Presbyterian-St. Lukes Medical Center. He then completed an internship at Rush Presbyterian St Lukes Medical Center a residency at Rush Presbyterian-St. Lukes Medical Center, and a fellowship at Indiana University Medical Center.
Dr. Loehrer currently has a rating of 4.8 stars out of 5 with over 50 ratings. Patients say that he is confident, empathetic, and impressive.
Dr. Loehrer's primary location is Multi-D Oncology Clinic, 535 Barnhill Dr, Indianapolis, IN 46202.
Insurance
Insurance plans accepted by this provider are below.
American Health Plan of Indiana/Majestic Care Management (I-SNP Only)
Cigna
Community Health Alliance
Community Health System
Coventry/First Health
Deaconess OneCare
IU Health Plans
Johnson County Health Network
Lutheran Preferred
MultiPlan/PHCS
NaphCare
Sagamore Health Network
Select Health Network
SIHO
Note: Although this listing was accurate at the time of posting, insurances change regularly, and insurance plans listed may not be accepted at all office locations for this provider. Please confirm with your insurance company that this provider is covered by your plan before your appointment.
Locations
Specialties & Details
Specialties:
Hematology - Oncology
Conditions & Treatments:
Gastrointestinal Cancer, Thoracic Cancer, Thymoma Cancer
Education
School of Medicine:
Rush Presbyterian-St. Lukes Medical Center
Internship:
Rush Presbyterian St Lukes Medical Center
Residency:
Rush Presbyterian-St. Lukes Medical Center
Fellowship:
Indiana University Medical Center
Hospitals & Affiliations
Hospital Privileges:
IU Health Methodist/IU Health University, IU Health North
Physician Group:
IU Health Medical Group
Research
Research Publications
* Information provided by PubMed
Related Services
Ratings & Reviews
Overall Provider Rating
Patients' feedback on the following attributes:
Clinical Trials
Explore the ongoing clinical trials this provider is involved in and learn about the eligibility requirements for each one. Search the clinical trial directory to find additional clinical trials.
Phase II Randomized Double-Blind Study of mFOLFIRINOX plus Ramucirumab versus mFOLFIRINOX plus placebo in Advanced Pancreatic Cancer Patients HCRN GI14-198
View DetailsMolecular and Pathological Correlates of Treatment Outcome in Patients with Thymoma and Thymic Carcinoma
View DetailsA Phase I/II, Open-Label Study to Investigate the Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics of GSK3145095 Administered Alone and in Combination With Anticancer Agents Including Pembrolizumab in Adult Participants With Selected Advanced Solid Tumors
View DetailsRelated Stories
Patient Stories
Read More
Patient is lost for words to describe gratitude - She’s giving back
IU Health Simon Cancer Center — After her own hospitalization, this patient is bri...